Ovid Therapeutics
OVID
0,26 €
Share price
-6.57%
Change (1 day)
-91.39%
Change (1 year)
Categories
EPS for Ovid Therapeutics (OVID)
EPS in 2023 (TTM): -0,66 €
According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,64 €. In 2022 the company made an earnings per share (EPS) of -0,70 € a decrease over its 2021 EPS that were of 1,61 €.
EPS history for Ovid Therapeutics from 2016 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -0,66 € | -5.26% |
| 2022 | -0,70 € | -143.5% |
| 2021 | 1,61 € | -226.43% |
| 2020 | -1,27 € | -11.39% |
| 2019 | -1,43 € | -25.47% |
| 2018 | -1,92 € | -23.94% |
| 2017 | -2,53 € | 143.74% |
| 2016 | -1,04 € |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -1,98 € | 211.43% | 🇺🇸 USA |